Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 7, July 2018, Pages 471-549
 
MONOGRAPHS
 
  
 Anifrolumab.
Anti-interferon-α receptor 1 (IFNAR1) monoclonal antibody Treatment of systemic lupus erythematosus.
Haddley, K.
Drugs Fut 2018, 43(7): 471
Summary | Full Text: PDF 
 
  
  
 Bimekizumab.
Humanized monoclonal antibody demonstrating dual inhibition of IL-17A and IL-17F Treatment of psoriasis and psoriatic arthritis infection.
Crowley, J.J.
Drugs Fut 2018, 43(7): 483
Summary | Full Text: PDF 
 
  
  
 Crizanlizumab.
Anti-P-selectin monoclonal antibody Prevention of sickle-cell-related pain crises.
Kanter, J.
Drugs Fut 2018, 43(7): 489
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Update on Wilson disease: focus on WTX-101.
Camarata, M.A., Ala, A., Schilsky, M.L.
Drugs Fut 2018, 43(7): 501
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Gonzalez Brao, M.M., Mila, M., Torramade, E.
Drugs Fut 2018, 43(7): 509
Full Text: PDF 
 
  
  
 NME Digest.
Bofill, X., Cole, P., Fernandez-Forner, D., Torramade, E.
Drugs Fut 2018, 43(7): 521
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 European Association for the Study of the Liver – 53rd International Liver Congress Paris, France – April 11-15, 2018.
Croasdell, G.
Drugs Fut 2018, 43(7): 537
Summary | Full Text: PDF 
 
  
  
 Clinical Microbiology and Infectious Diseases (ECCMID) - 28th European Congress.
Tur, J.
Drugs Fut 2018, 43(7): 545
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences